HOUSE_OVERSIGHT_024666.jpg
1.05 MB
Extraction Summary
0
People
4
Organizations
0
Locations
0
Events
0
Relationships
3
Quotes
Document Information
Type:
Investment report / market research
File Size:
1.05 MB
Summary
This document is page 30 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital, LLC. It contains a table titled 'Representative Dosage Amounts' detailing THC and CBD dosages for various ailments (e.g., Anxiety, Cancer, Glaucoma) and a paragraph discussing the lack of thorough research on the medical benefits and side effects of cannabis. The document bears the stamp 'HOUSE_OVERSIGHT_024666', indicating it is part of a document production to the House Oversight Committee, likely related to a financial investigation.
Organizations (4)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC | ||
| FINRA | ||
| SIPC | ||
| House Oversight Committee |
Key Quotes (3)
"Neither the potential medicinal benefits and therapeutic applications of cannabis consumption nor the negative side effects of cannabis use have been thoroughly researched by medical science."Source
HOUSE_OVERSIGHT_024666.jpg
Quote #1
"Short-term negative side effects are believed by some to include sensory distortion, panic, anxiety, poor coordination of movement..."Source
HOUSE_OVERSIGHT_024666.jpg
Quote #2
"There is also an ongoing debate about whether cannabis consumption may lead to the abuse of more harmful substances (the so-called 'gateway drug' debate)."Source
HOUSE_OVERSIGHT_024666.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document